The field of nanomedicines has expanded
significantly in recent years in the breadth of compounds under development as
well as in the types
of technology that are being applied to
generate nanomedicines. The pathway to licensure of new
nanomedicines is sufficiently well
defined by existing regulations and guidance.
The future of nanomedicines requires collaboration between industry and regulatory
agencies to ensure that safe and effective nanomedicines emerge from this
field.
No comments:
Post a Comment